It has been reported that the tumor necrosis factor (TNF)α promoter polymorphism is associated with autoimmune disease and inflammatory disease. It has also been claimed that this polymorphism may affect TNFα expression. We investigated the TNFα –308 polymorphism and TNFα levels in 79 unrelated Chinese patients with Guillain-Barré syndrome (GBS) and 78 healthy controls using PCR-RFLP and ELISA assay. Patients with GBS were divided into 2 subgroups, acute inflammatory demyelinating polyradiculoneuropathy (AIDP) and acute motor axonal neuropathy (AMAN), based on electrophysiological information. We found that the TNFα2 allele was associated with increased risk of GBS (OR = 1.876, 95% CI = 1.144–3.075, p = 0.008), particularly for AMAN, the main subtype (OR = 2.914, 95% CI = 1.412–6.015, p = 0.004), but there was no association between TNFα polymorphism and AIDP. We also found that carriers of the TNFα2 allele had significantly higher TNFα2 levels than TNFα1 homozygotes (p < 0.05). These data indicate that TNFα promoter polymorphism is responsible for susceptibility to GBS, especially to AMAN. The TNFα2 allele is associated with higher levels of TNFα.